Sitagliptin Phosphate Tablets IP 50 mg

Introduction

GLISITAPTIN M 50/500 is an advanced oral antidiabetic medication that combines Sitagliptin Phosphate (50mg) and Metformin Hydrochloride (500mg). This dual-action therapy effectively regulates blood sugar levels in patients with Type 2 Diabetes Mellitus (T2DM) by improving insulin secretion and reducing glucose production. Manufactured by Steris Healthcare Pvt Ltd, this medication adheres to WHO-GMP and ISO standards, ensuring efficacy, safety, and high-quality diabetes management.

Key Features and Ingredients

1. Sitagliptin Phosphate (50mg)

• A DPP-4 inhibitor that helps increase insulin production in response to meals.

• Reduces postprandial blood sugar spikes.

• Enhances beta-cell function in the pancreas.

2. Metformin Hydrochloride (500mg)

• A biguanide that decreases hepatic glucose production.

• Improves insulin sensitivity and promotes glucose uptake.

• Helps in weight management and reduces diabetes-related complications.

Uses of GLISITAPTIN M 50/500

• Effectively manages Type 2 Diabetes Mellitus (T2DM).

• Enhances insulin secretion and glucose utilization.

• Reduces fasting and postprandial blood glucose levels.

• Minimizes the risk of diabetes-related complications such as neuropathy and nephropathy.

• Aids in weight management by regulating blood sugar more effectively.

Dosage and Administration

• Recommended Dosage: As prescribed by a healthcare professional.

• Should be taken once or twice daily with meals to improve absorption and reduce gastrointestinal side effects.

• Regular blood sugar monitoring is essential for optimal results.

• Do not skip doses to maintain consistent blood sugar levels.

Possible Side Effects

• Mild gastrointestinal discomfort (nausea, bloating, or diarrhea).

• Headache or dizziness in some individuals.

• Risk of lactic acidosis in rare cases (seek immediate medical attention if symptoms occur).

• Hypoglycemia when combined with other antidiabetic medications.

• Allergic reactions (rash, swelling) in rare cases.

Precautions and Warnings

• Not suitable for patients with severe kidney or liver impairment.

• Avoid excessive alcohol consumption, as it may increase the risk of lactic acidosis.

• Pregnant or breastfeeding women should consult a doctor before use.

• Use cautiously in patients with cardiac conditions or gastrointestinal disorders.

• Monitor kidney function regularly during long-term therapy.

Why Choose GLISITAPTIN M 50/500 by Steris Healthcare Pvt Ltd?

• Dual-action mechanism for effective diabetes control.

• Manufactured under WHO-GMP and ISO-certified facilities.

• Minimizes risk of long-term diabetes complications.

• Widely available at leading pharmacies and online stores.

• Trusted by healthcare professionals for its safety and efficacy.

Price and Availability

• Price: Varies based on region and pack size.

• Availability: Accessible at major pharmacies and online platforms.

• Packaging: Comes in tablet form for easy administration.

• Prescription Required: Yes, consult a doctor before use.

Frequently Asked Questions (FAQs)

1. How does GLISITAPTIN M 50/500 help in diabetes management?

• It enhances insulin secretion and reduces glucose production, ensuring stable blood sugar levels.

2. Can I take this medication with other diabetes medicines?

• Always consult your doctor before combining it with other oral hypoglycemic agents or insulin.

3. How soon will I see results with GLISITAPTIN M 50/500?

• Most patients experience improved blood sugar levels within a few weeks of consistent use.

4. Does GLISITAPTIN M 50/500 cause weight gain?

• Metformin helps prevent weight gain, while Sitagliptin does not significantly affect weight.

5. What should I do if I miss a dose?

• Take it as soon as you remember, but do not double the dose to compensate.

6. Is this medicine suitable for elderly patients?

• Yes, but dosage adjustments may be necessary based on kidney function and overall health.

Conclusion

GLISITAPTIN M 50/500 is a highly effective oral antidiabetic medication that combines Sitagliptin and Metformin for comprehensive diabetes management. With Steris Healthcare Pvt Ltd’s commitment to quality, patients can trust this formulation for enhanced blood sugar control and improved metabolic health. For those seeking a reliable and safe diabetes treatment, GLISITAPTIN M 50/500 is an excellent choice for a healthier lifestyle and better glucose management.

About The Author

STERIS HEALTHCARE PVT LTD

Steris Healthcare Pvt Ltd, known as Sterispharma, was founded in February 2018 by a team of experienced professionals in the pharmaceutical industry. Headquartered in Navi Mumbai, the company holds certifications from WHO, GMP, and ISO, reflecting its dedication to maintaining high standards of quality and safety. Sterispharma’s mission is to provide affordable, high-quality medications across India, strictly adhering to WHO guidelines. With the convenience of an online pharmacy, customers can easily order medicines with home delivery options.

For further information 

Email: info@sterispharma.com / contact@sterispharma.com

Call/WhatsApp: 8209542042 , 8824175417

BUY NOW